Abstract
Pyrexia of unknown origin (PUO) and suspected focal infection/inflammation are challenging medical problems. Nuclear medicine methods using scintigraphy with 111In- or 99mTc-labelled antibodies or 67Ga-citrate have been validated for the diagnosis and detection of inflammatory processes. Recently, positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) has been described as a promising imaging method, especially for PUO. We report the use of FDG-PET in an 18-month-old boy that revealed unexpected infectious colitis after cardiac surgery. This case suggests that FDG-PET is a valuable tool for the detection of unknown inflammatory foci in childhood, especially when the time needed for examination and radiation exposure are to be considered.
Similar content being viewed by others
References
Becker W, Meller J (2001) The role of nuclear medicine in infection and inflammation. Lancet Infect Dis 1:326–333
Bleeker-Rovers CP, de Kleijn EM, Corstens FH,et al (2004) Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur J Nucl Med Mol Imaging 31:29–37
Tatlidil R, Jadvar H, Bading JR ,et al (2002) Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings. Radiology 224:783–787
Neurath MF, Vehling D, Schunk K, et al (2002) Noninvasive assessment of Crohn’s disease activity: a comparison of 18F-fluorodeoxyglucose positron emission tomography, hydromagnetic resonance imaging, and granulocyte scintigraphy with labelled antibodies. Am J Gastroenterol 97:1978–1985
Piepsz A, Hahn K, Roca I, et al (1990) A radiopharmaceuticals schedule for imaging in paediatrics. Paediatric Task Group European Association Nuclear Medicine. Eur J Nucl Med 17:127–129
International Commission on Radiological Protection (1999) Radiation doses to patients from radiopharmaceuticals. IRCP publication 80, Washington
Gratz S, Behr TM, Herrmann A ,et al (1998) Immunoscintigraphy (BW 250/183) in neonates and infants with fever of unknown origin. Nucl Med Commun 19:1037–1045
Becker W (1999) Guidelines for technetium-99m antigranulocyte scintigraphy in inflammatory or infectious diseases (in German). Nuklearmedizin 38:249–250
International Commission on Radiological Protection (1999) Addendum 3 to ICRP publication 53 (Radiation Dose to Patients from Radiopharmaceuticals). http://www.icrp.org. Cited 26 Sep 2000
Minkov V, Hornik S, Brix G, et al (2004) Einfluss der Häufigkeit der Blasenentleerung auf die Strahlenexposition von Patienten im Kindesalter nach Applikation von F-18-markierten Radiopharmaka. Nuklearmedizin 43:A117
Hall EJ (2002) Lessons we have learned from our children: cancer risks from diagnostic radiology. Pediatr Radiol 32:700–706
Peters AM (1998) The use of nuclear medicine in infections. Br J Radiol 71:252–261
Oyen WJ, Mansi L (2003) FDG-PET in infectious and inflammatory disease. Eur J Nucl Med Mol Imaging 30:1568–1570
Blockmans D, Knockaert D, Maes A, et al (2001) Clinical value of [(18)F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis 32:191–196
Buscombe J, Signore A (2003) FDG-PET in infectious and inflammatory disease. Eur J Nucl Med Mol Imaging 30:1571–1573
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ruf, J., Griebenow, B., Stiller, B. et al. Detection of infectious colitis by 18F-fluorodeoxyglucose-positron emission tomography in a child receiving intensive care after cardiac surgery. Pediatr Radiol 35, 702–705 (2005). https://doi.org/10.1007/s00247-005-1404-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00247-005-1404-z